Please complete the CAPTCHA to continue
@intersectent.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
David J. Christopher is listed as President’s Club | Sales Leader | Disruptive Technology | Capital Equipment | Market Agitation | Start-up Medical Device | Product Launches | Team Development at Intrinsic Therapeutics, Inc, based in Syracuse, New York, United States. AeroLeads shows a work email signal at intersectent.com and a matched LinkedIn profile for David J. Christopher.
David J. Christopher previously worked as Barricaid Territory Manager | Field Sales Trainer at Intrinsic Therapeutics, Inc and Strategic Account Manager – Northern US Markets, Intersect ENT at Intersect Ent, Inc. David J. Christopher holds M.B.A., Business Administration from Marist College.
This section adds company-level context without repeating David J. Christopher's masked contact details.
AeroLeads found 1 current-domain work email signal for David J. Christopher. Compare company email patterns before reaching out.
* Multiple President’s Club Winner, Leader, Mentor, Trainer* High-achieving sales manager with a record of exceeding sales goals* Special competency in launching disruptive technology, capital equipment,instrumentation, disposables, focusing on market developmentCommercial payor execution and strategy and medical device markets* Widespread success in hiring, managing, and leading sales teams to achieve multimillion-dollar revenuegains, through economic downturns with no additional procedural reimbursement* Proven success in clinical and capital medical equipment sales with partnerships with C-level executivesand KOLs to drive business, shorten timelines and expand market share* Managers plan and coordinate….A leader inspires and motivates
Listed skills include Urology, Surgeons, Operating Room, Cardiology, and 15 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Woburn, Ma, Us
Barricaid is the only FDA PMA-approved technology indicated for reducing reherniation and reoperation after lumbar discectomy. 5-year #superiority #data published in #JAMA Open! There is no substitute for clinical evidence #barricaid
Minneapolis, Mn, Us
Minneapolis, Mn, Us
Intersect ENT has developed the PROPEL™ dissolvable implant for chronic sinusitis patients undergoing sinus surgery. PROPEL is the first of a new category of products offering localized, controlled drug delivery directly to the sinus tissue. Inserted by a physician to maintain the surgical opening, the spring-like implant expands to prop open the ethmoid sinus and gradually delivers an advanced corticosteroid (mometasone furoate) with anti-inflammatory properties directly to the sinus lining as the implant dissolves.The PROPEL system has been clinically proven to prevent obstruction of the ethmoid sinus following surgery. The result is improved post-operative outcomes, reducing the need for additional surgical procedures such as adhesion lysis and systemic steroids.
Minneapolis, Mn, Us
• President’s Club Winner• Top Growth Territory Manager of the Year Award (#1 out of 70 territories)• Promoted to Field Sales Trainer 2015• Elected to Sales and Marketing Advisory Council by peers (7 out of 85 representatives)• Selected for Top Performer Summit Executive council 2015 (5 out of 85 representatives)• Developed KOLs for Propel rollout across the Northeast and 1 clinical trial site• Selected for the mentorship and leadership development council for new representatives• Market disruption events including peer-to peer lectures, KOL speaker programs, and referral marketing programs • Launched the Propel implants in every major hospital system in Greater NY and the Northeast
California, 94086, Us
Global leader in the rapidly emerging field of robotic-assisted minimally invasive surgery. Since its inception, the company has consistently provided surgeons and hospitals with the tools needed to improve clinical outcomes and to help patients return to active and productive lives.The da Vinci Surgical System provides surgeons with an alternative to both traditional open surgery and conventional laparoscopy, putting a surgeon’s hands at the controls of a state-of-the-art robotic platform. The da Vinci System enables surgeons to perform even the most complex and delicate procedures through very small incisions with unmatched precision.
Quick answers generated from the profile data available on this page.
David J. Christopher works for Intrinsic Therapeutics, Inc.
David J. Christopher is listed as President’s Club | Sales Leader | Disruptive Technology | Capital Equipment | Market Agitation | Start-up Medical Device | Product Launches | Team Development at Intrinsic Therapeutics, Inc.
AeroLeads has found 1 work email signal at @intersectent.com for David J. Christopher at Intrinsic Therapeutics, Inc.
David J. Christopher is based in Syracuse, New York, United States while working with Intrinsic Therapeutics, Inc.
David J. Christopher has worked for Intrinsic Therapeutics, Inc, Intersect Ent, Inc, Intuitive Surgical, and Pfizer.
You can use AeroLeads to view verified contact signals for David J. Christopher at Intrinsic Therapeutics, Inc, including work email, phone, and LinkedIn data when available.
David J. Christopher holds M.B.A., Business Administration from Marist College.
David J. Christopher is listed with skills including Urology, Surgeons, Operating Room, Cardiology, Pharmaceutical Sales, Medical Devices, Capital Equipment, and Orthopedic.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts